Adverse event was reportedly myocarditis.

Moderna halted a clinical trial for a new vaccine because one of the participants suffered an adverse event, The Epoch Times has confirmed.

Workers at two of the trial sites said the trial for the Epstein-Barr virus vaccine, which launched in early 2022, was paused.

One of the workers said the trial was halted due to an issue with one of the participants.

Posted in

Iron Will

Leave a Comment

You must be logged in to post a comment.